|
The customer observed falsely decreased architect total bilirubin generated from architect analyzer and provided the following data: the customer reported that they were getting total bilirubin results < 0.2 mg/dl and upon repeat they were getting actual numbers.The customer communicated that 40 patients' results required correction.The customer confirmed that there was no improper treatment due to the results.Result values not provided, but the following example was provided.On (b)(6) 2025, sample id (b)(6) initial result was < 0.2 mg/dl and repeat result was 0.3 mg/dl.Customer reference range is 0.2-1.3 mg/dl there was no reported impact to patient management.
|
|
The field service representative (fsr) inspected the instrument and replaced the probe wash bellows set, incl rod and fitting (rohs).Additionally, the fsr rebuilt the r2 syringe by replacing the rgt seal tip 1, rgt seal tip 2, and the rgt syr o-rng.Replacement of the parts resolved the issue which was verified with a passing quality control run.No additional discrepant result issues have been reported since the service activity was completed.The instrument service history review for (b)(6) revealed no additional service tickets associated with discrepant/erratic patient results.There were no additional service or complaint issues on or around the date this complaint was initiated that may have contributed to this issue.A review of tracking did not identify any trends for the parts that were replaced.A review of tracking and trending did not identify any similar issues related to the architect system, likely cause parts, or discrepant results as described in this ticket.A review of manufacturing documentation did not identify any non-conformances related to the complaint issue.Labeling was reviewed and found to be adequate.Based on the available information, no systemic issue or deficiency of the architect c8000 processing module, the bellows set, incl rod & fitting (rohs), rgt seal tip 1, rgt seal tip 2, or the rgt syr o-rng was identified.
|
|
The customer observed falsely decreased architect total bilirubin generated from architect analyzer and provided the following data: the customer reported that they were getting total bilirubin results < 0.2 mg/dl and upon repeat they were getting actual numbers.The customer communicated that 40 patients' results required correction.The customer confirmed that there was no improper treatment due to the results.Result values not provided, but the following example was provided.On (b)(6) 2025, sample id (b)(6) initial result was < 0.2 mg/dl and repeat result was 0.3 mg/dl.Customer reference range is 0.2-1.3 mg/dl there was no reported impact to patient management.
|